Difference Between Epithalon and NAD+ — Peptide vs Coenzyme | Real Peptides
Research from the St. Petersburg Institute of Bioregulation and Gerontology demonstrated that Epithalon extended mean lifespan in rodent models by 13.3% through telomerase activation. A mechanism entirely distinct from metabolic intervention. NAD+ (nicotinamid
This comparison does not assign a generated winner or score.
- Research from the St. Petersburg Institute of Bioregulation and Gerontology demonstrated that Epithalon extended mean lifespan in rodent models by 13.3% through telomerase activation. A mechanism entirely distinct from metabolic intervention. NAD+ (nicotinamide adenine dinucleotide), by contrast, functions as a coenzyme in over 400 enzymatic reactions that govern mitochondrial respiration, DNA repair, and circadian rhythm regulation. These are not interchangeable pathways.
- Our team has sourced research-grade peptides for institutions studying both telomere biology and metabolic aging. The difference between Epithalon and NAD+ isn't just molecular structure. It's the biological question each compound addresses. One asks 'how do we preserve genetic integrity across cell divisions?' The other asks 'how do we maintain energy production as mitochondrial function declines?'
- What is the difference between Epithalon and NAD+?
- Epithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) that activates telomerase and regulates pineal gland function, extending cellular replicative capacity. NAD+ is a dinucleotide coenzyme present in all living cells that accepts and donates electrons during cellular respiration, enabling ATP synthesis. Epithalon acts on chromosomal preservation; NAD+ drives metabolic flux. Structurally unrelated, they target different aging mechanisms. Telomere shortening versus bioenergetic decline. And are studied in distinct research contexts with minimal functional overlap.
- The confusion between these two compounds stems from their shared positioning in anti-aging literature, not their biological function. Epithalon belongs to the class of peptide bioregulators developed by Vladimir Khavinson's research group in Russia, originally studied for neuroendocrine effects and later for telomere elongation. NAD+ is a fundamental metabolic coenzyme whose decline with age has been documented across mammals, prompting research into NAD+ precursors like NMN and NR. This article covers the structural and functional differences, the distinct research applications of each compound, and the scenarios where one or both might be relevant to longevity studies.